BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Drug Development

  Quark Pharmaceuticals Inc. Announces Completion Of Phase 2 Trial Evaluating QPI-1002 For Prevention Of Delayed Graft Function In Kidney Transplant Patients

  July 1, 2014

   · 

  1 min read
• BioCapital

  Nuvilex Executives Attend 2014 Biotechnology Industry Organization (BIO) International Convention

  July 1, 2014

   · 

  1 min read
• Biotech Bay

  Trigemina Presented At American Headache Society 56th Annual Scientific Meeting

  July 1, 2014

   · 

  1 min read
• Drug Development

  Ultragenyx Pharmaceuticals Announces Initiation Of A Phase 2 Study Of KRN23 For Pediatric X-Linked Hypophosphatemia In The US And EU

  July 1, 2014

   · 

  1 min read
• Cardio3 BioSciences Announces Completion Of Its Capital Increase Of €25 Million At €44 Per Share

  July 1, 2014

   · 

  3 min read
• Biotech Bay

  WaferGen Biosystems Announces Reverse Stock Split As It Pursues NASDAQ Listing

  July 1, 2014

   · 

  4 min read
• Pharm Country

  Agile Therapeutics, Inc. Joins Russell Microcap® Index

  July 1, 2014

   · 

  1 min read
• Drug Development

  AVANIR Pharmaceuticals Announces Two Data Presentations Related To Pseudobulbar Affect (PBA) At The Alzheimer’s Association International Conference (AAIC)

  July 1, 2014

   · 

  7 min read
• Pharm Country

  Inovio Pharmaceuticals Added To Russell Global, Russell 2000® and Russell Microcap® Indexes

  July 1, 2014

   · 

  5 min read
• Pharm Country

  Relmada Therapeutics Files Shares Registration Statement

  July 1, 2014

   · 

  3 min read